Business
New cannabinoid R&D collaboration
New cannabinoid R&D collaboration.
About this update from Chill Brands Group Plc
[{"type":"text","content":"\n \nRNS Number : 2245A Highlands Natural Resources PLC 28 May 2019 \n\nTHE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \n \n28 May 2019\n \nHighlands Natural Resources plc \n(\"Highlands\" or the \"Company\") \n \nNew cannabinoid R&D collaboration\nFirst patent filed\n \nHighlands, the London-listed natural resources company, is pleased to provide the following update on developments at Zoetic, the premium and organic producer of CBD products and wholly-owned subsidiary of the Company.\n \nFurther to Highlands' trading update on 9 May 2019, in which it outlined the Company's strategy to produce feminised hemp seeds for sale to other hemp producers at its 33,000 sq ft state of the art growing facility, Highlands today announces a collaboration with analytical chemist Stephen Goldman, to examine, develop and file patents and other intellectual property on behalf of Company in the areas of (i) agricultural genetics and (ii) pharmaceutical and wellness products based on, or incorporating, cannabinoids.\n \nMr Goldman has considerable experience in the field of cannabinoids and has developed several propositions in these areas and has agreed to work with Highlands, in conjunction with the Company's activities at Zoetic, to bring these developments to commercial success. It is anticipated that Mr Goldman's expertise in agricultural genetics will enhance Zoetic's existing work on developing the most suitable strains of hemp for seed production. Mr Goldman's research also brings to Highlands an additional area to exploit the potential medical and wellness benefits of the physical combination of cannabinoids with other active ingredients.\n \nHighlands is pleased to announce that it has already filed the first patent in relation to Mr Goldman's work. The patent relates to the methodology for combining cannabinoids with pharmaceutical and wellness products.\n \nHighlands will fund the costs of the collaboration and Mr Goldman has agreed that all intellectual property that is developed will be owned by Highlands. The costs, which ...